Pharmacists Transform Chronic Disease Care: Expanded Roles & Outcomes

Here’s a list of the references, formatted for easier readability:

1. CDC: https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html
2. Benavidez GA, Zahnd WE, Hung P, Eberth JM. Chronic disease prevalence in the US: sociodemographic and geographic variations by ZIP code tabulation area. Prev Chronic Dis. 2024;21:E14.doi:10.5888/pcd21.230267
3. The growing burden of chronic diseases. NIHCM Foundation. April 3, 2025. Accessed December 1, 2025.https://nihcm.org/publications/the-growing-burden-of-chronic-diseases
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-543.
5. Alhabib S,Aldraimly M,alfarhan A. An evolving role of clinical pharmacists in managing diabetes: evidence from the literature. Saudi Pharm J. 2016;24(4):441-446.doi:10.1016/j.jsps.2014.07.008
6. Brummel A, Carlson AM. Comprehensive medication management and medication adherence for chronic conditions. J Manag Care Spec Pharm. 2016;22(1):56-62. doi:10.18553/jmcp.2016.22.1.56
7. Marupuru S, Roether A, guimond AJ, Stanley C, Pesqueira T, Axon DR. A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. Healthcare (Basel). 2022;10(7):1207. doi:10.3390/healthcare10071207
8. Orehovački H, Brajković A, Bićanić LA, Mucalo I. Polypharmacy – is there a cure for drug therapy problems?. Croat Med J. 2023;64(4):295-300. doi:10.3325/cmj.2023.64.295
9. Budlong H, Brummel A, Rhodes A, Nici H. Impact of comprehensive medication management on hospital readmission rates. Popul Health Manag. 2018;21(5):395-400.doi:10.1089/pop.2017.0167
10. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J Multidiscip Healthc. 2021;14:1701-1710. doi:10.2147/JMDH.S309938
11. Agomo C, Udoh A, Kpokiri E, Osuko-Opio J. Community pharmacists’ contributions to public health: assessing the global evidence base. the Pharmaceutical Journal. 2018;10(4). doi:10.1211/PJ.2018.20204556
12. Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist–led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. res Social Adm Pharm. 2020;16(9):1155-1165. doi:10.1016/j.sapharm.2019.12.016
13. Newman TV, Hernandez I, Keyser D, et al. Optimizing the role of community pharmacists in managing the health of populations: barriers, facilitators, and policy recommendations. J Manag Care Spec Pharm. 2019;25(9):995-1000. doi:10.18553/jmcp.2019.25.9.995